Thames Valley Cytology Society

Volume 4 Issue 2
June 2001

 

Cervical cancer in England and Wales - Effect of Cervical Screening

Report by Dr Tony Maddox

 

TVCS scientific meeting and AGM, 15 February 2001, at University College, London

Dr Amanda Herbert from St. Thomas's Hospital kindly agreed to come and describe her recent work which attempted to address two criticisms of cervical screening in general and the NHS Cervical Screening Programme (NHSCSP) in particular - namely that cervical cancer is a rare disease and too much effort and money is spent on screening and that cervical screening has, in any case, been ineffective. This involved examining data from the Office of National Statistics (available on their website - http://www.statistics.gov.uk/) regarding registration and incidence of invasive cervical cancer and carcinoma-in-situ (CIS) by 5 year birth cohort and age at registration.

A brief history of the introduction of cervical screening in the UK reiterated the fact that it was introduced sporadically in a few centres in the 1950's, nationally in 1967, (via payments to GP's) and became more widespread in the 1980's as Health Authorities introduced call and recall systems. The NHSCSP was established in 1988. The figures for the incidence of invasive cervical cancer show it to have declined gradually until 1983, and then increased until around 1988, following which there has been a sharp decline (so far 40% compared to 1988 levels). This has led to the conclusion that cervical screening was ineffective before 1988. Furthermore, despite the demonstrable improvement since 1988, criticism continues and staff morale, retention and recruitment are increasingly difficult.

Firstly, the figures for the registrations of cervical cancer and CIS were shown in graphical form for the years 1971, 1981 and 1991. There was a roughly 8-fold (700%) increase in CIS with time while the registrations for invasive cancer had fallen only slightly (about 10%). There had also, incidentally, been a shift in the age with most registrations from the 30-34 to the 25-29 age group. This raised the question of why, when so many more cases of CIS were being detected and treated, was there so small an effect on the registrations of cervical cancer?

Examination of 5-year birth cohorts (i.e. groups of women born within 5 years of each other) showed that there was a marked increase in CIS, particularly, and invasive carcinoma in the cohorts born from 1937 onwards which was difficult to explain by increased rates of detection and seemed to indicate a true increase in disease risk. By contrast, those born in the 1920's and early 1930's appeared to have a genuinely lower risk of disease.

Therefore, it is possible to draw the conclusion that cervical cancer registrations remained relatively static in the 1970's and most of the 1980's because screening, though far from perfect, was preventing a significant minority of cervical cancers in higher-risk women who had come of age two decades previously, thus effectively cancelling out an increase. Some estimates suggest that screening was preventing about 25% of cancers in the mid-1980's. This contrasts with estimates around 80-90% today.

Dr Herbert has contributed a great deal to the development and implementation of cervical screening and is committed to and passionate about her chosen field. It was a relief to hear a positive message delivered with enthusiasm and gratifying, also, that these conclusions found their way into the national press, subsequently.